Johnson & Johnson

Product / Service

Johnson & Johnson

Johnson & Johnson's Janssen Therapeutic receives FDA approval for Juluca, the first combination of two drugs in a single-pill regimen for treatment of HIV-1 infection

Stock Report

Johnson & Johnson company details

Johnson & Johnson is a holding company. Through its subsidiaries, Co. engages in three business segments. The Consumer segment includes products used in the baby care, skin care, oral care, wound care and women's health care fields, and nutritional and over-the-counter pharmaceutical products, and wellness and prevention platforms. The Pharmaceutical segment includes products in the areas of anti-infective, antipsychotic, contraceptive, gastrointestinal, hematology, immunology, infectious diseases, neurology, oncology, pain management, thrombosis and vaccines. The Medical Devices and Diagnostics segment includes products used principally by physicians, nurses, hospitals, and clinics.

Address: One Johnson & Johnson Plaza, New Brunswick, NJ 08933 | Tel: 732 524-0400 | http://www.jnj.com

Trending Topics

AIDS/HIV-Positive
Administrative/R&D Facilities
Approved Drugs/Devices
Beauty Retail
Beauty Use
Branded Drugs
Brick-and-Mortar Retail
Capsules/Pills/Tablets
Cardiovascular Conditions
Diabetes

Financial Coverage

19,650 millions US$
3,764 millions US$
6,420 millions US$
32.67%
July 2017
2017-12-13
USA

Related Companies

Integra LifeSciences Holdings ...
Janssen Biotech Inc.
Janssen Pharmaceuticals Inc.
Vogue International LLC

Additional News

Johnson & Johnson Financial References

JNJ - Market Cap
JNJ - Volume
JNJ - Shares outstanding
JNJ - Cash & Equivalents
JNJ - Dividends Paid (TTM)
JNJ - EPS Basic (TTM)
JNJ - EBITDA (TTM)
JNJ - Debt-to-Capital Ratio
JNJ - Working Capital
JNJ - Cash Flow from Financing
JNJ - Cash Flow from Investments
JNJ - Cash Flow from Operations
JNJ - Dividends Paid
JNJ - Total Current Assets
JNJ - Total Debt
JNJ - Net Debt
JNJ - Free Cash Flow
JNJ - Total Capital
JNJ - EPS - Basic
JNJ - Capital Expenditures (CAPEX)
JNJ - EBITDA Margin
JNJ - EBITDA
JNJ - Gross Income Margin
JNJ - Cash Ratio
JNJ - Debt-to-Equity
JNJ - Total Assets
JNJ - Total Current Liabilities
JNJ - Total Liabilities
JNJ - Total Equity
JNJ - Sales
JNJ - Gross Income
JNJ - Operating Income
JNJ - Earnings
JNJ - Net Income Margin
JNJ - EPS - Diluted
JNJ - EBIT
JNJ - Sales (TTM)
JNJ - EPS Diluted (TTM)
JNJ - Gross Income (TTM)
JNJ - Operating Income (TTM)
JNJ - EBIT (TTM)
JNJ - Earnings (TTM)
JNJ - Research & Development Expense
JNJ - Net Income Applicable to Common
JNJ - Net Income Applicable to Common (TT
JNJ - Net Income per Employee
JNJ - Net Income per Employee (TTM)
JNJ - Research & Development Expense (TTM
JNJ - Revenue per Employee
JNJ - Revenue per Employee (TTM)

All content is copyrighted by Industry Intelligence, and the original respective author or source. You may not copy, recirculate, redistrubte or publish the content and presentation included in the service without Industry Intelligence's prior written consent. Please review our terms of use.